Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 75,040 | 74,516 | 73,427 | 70,176 | 73,061 |
| Cost of Goods | 48,654 | 49,164 | 29,726 | 46,007 | 46,838 |
| Gross Profit | 26,386 | 25,352 | 43,701 | 24,169 | 26,223 |
| Operating Expenses | 32,048 | 35,508 | 33,426 | 35,362 | 34,354 |
| Operating Income | -5,008 | -9,992 | 11,001 | -11,186 | -7,293 |
| Interest Expense | 236 | 234 | 2,404 | 5,868 | 6,158 |
| Other Income | 532 | 526 | 489 | 552 | 391 |
| Pre-tax Income | -4,712 | -9,700 | 9,086 | -16,502 | -13,060 |
| Net Income Continuous | -4,712 | -9,700 | 9,086 | -16,502 | -13,060 |
| Net Income | $-4,712 | $-9,700 | $9,086 | $-16,502 | $-13,060 |
| EPS Basic Total Ops | -0.14 | -0.29 | 0.28 | -0.50 | -0.40 |
| EPS Basic Continuous Ops | -0.14 | -0.29 | 0.28 | -0.50 | -0.40 |
| EPS Diluted Total Ops | -0.14 | -0.29 | 0.28 | -0.50 | -0.40 |
| EPS Diluted Continuous Ops | -0.14 | -0.29 | 0.28 | -0.50 | -0.40 |
| EBITDA(a) | $-1,149 | $-6,120 | $26,837 | $21,375 | $25,210 |